Author

Nico-al Paolo Gotera

Institution: Mercy Medical Center North Iowa

Observed institutions: The University of Texas at San Antonio Health Science Center, Mercy Medical Center North Iowa

OpenAlex ID: A5117229498

GLP-1 receptor agonists for primary prevention of breast cancer in high-risk women: A real-world analysis of efficacy and safety.

2026 · Nico-al Paolo Gotera, Colton Jones, et al. · Journal of Clinical Oncology · 1

Primary prevention of acute leukemias in high-risk patients: The therapeutic promise of GLP-1 receptor agonists.

2026 · Jonathan Dao, Ariana N. Neely, et al. · Journal of Clinical Oncology · 1

GLP-1 receptor agonists vs 5-alpha reductase inhibitors for prostate cancer primary prevention in high-risk men: A real-world head-to-head comparison.

2026 · Oscar Hinojosa, Nico-al Paolo Gotera, et al. · Journal of Clinical Oncology

Abstract 842: Early clinical outcomes of pembrolizumab plus neoadjuvant chemotherapy in early stage triple negative breast cancer in a Hispanic majority community

2025 · Aymen Baig, Erin C. Kaser, et al. · Cancer Research

Works count: 4

Citation count: 2

H-index: 1

I10-index: